Supplements
McGlynn is determined to find the HIV vaccine. World Aids Day Supplement
Publish Date: Dec 02, 2011
Shialendraumar Lal
  • mail
  • img

Uganda Virus Research Institute (UVRI) at Entebbe is one of the leading HIV research institutes in Uganda. Its main partner, International AIDS Vaccine Initiative (IAVI) is based in New York, USA. IAVI’s new CEO, Margie McGlynn was in Uganda last month and gave Halima Shaban an exclusive interview

Qn: How did you end up IAVI CEO?

I have been in the pharmaceutical industry for 26 years. My father was a pharmacist and I lost my two sisters and a brother to preventable diseases. In my previous portfolio, I had a measles vaccine and measles has virtually been eliminated in many countries. I want to do the same for HIV.

Qn: What is your vaccine experience?

I am an experienced biopharmaceutical executive with expertise in the vaccine and antiretroviral markets. I spent 26 years with Merck where
I launched several initiatives to provide access for Merck vaccines and HIV therapies in the developing world.
 After 2009, I became President, Global Vaccines and Anti-Infectives, with a $7b portfolio of products.
I also served on the board and executive committee of the GAVI alliance which provides life-saving vaccines against common infectious diseases.
I also played a major role in the formation of the Hilleman Centre, a research centre focused on developing new vaccines for the developing world.

Qn: Impressive! Ugandans want to know, will there be an HIV vaccine in our lifetime?

Absolutely! I am committed to that. I do not think we need events for a wheel chair before getting into an office chair. I cannot give a time line. It is not in the next few years but the biggest opportunity has already come with the studies in Bangkok which demonstrated 30% efficacy and subsequent trials are now planned in Bangkok and South Africa. We need to follow the lead we have to see an HIV vaccine over our life time.

Qn: What is your biggest challenge?

It is at a science level. The HIV keeps on changing and so our target changes consistently.  Even if your body develops a new response, the virus changes its attack. It also attacks the immune cells, which are the very cells you need to fight it. Apart from the science, there is the funding problem.

Qn: How will you manage with the global financial crisis?

I believe if IAVI continues to demonstrate value through successful studies, protocols and clinical trials, we will continue to be well positioned as a high quality product development partnership.
If we show that we can help turn promising vaccine concepts into products, funders will appreciate our importance

Qn: Are you satisfied with the facilities at UVRI?

Oh yes I am. The clinical trial facilities and the laboratory facilities are first class and have a tremendous face upon which to build for the future. The staff is very dedicated and the leaders are very passionate.

Qn: What would you like to improve?

One of my highest priorities is to make sure IAVI continues to partner successfully with all other key participants in the quest for an HIV vaccine. We are combining efforts because we have formidable challenges and we continue working, contacting each other and finding signs across our capabilities in programmes that can lead to the development of a vaccine in the shortest time possible.

Qn: Any additional support you expect from Uganda?

The Government has been a very important partner. They have supported us in every study we want to do. So, I expect this support to continue in future.

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Fifty years ago, nearly half of the African continent had just become independent. After decades of colonial rule under France, Britain, Italy and Belgium that had a lasting effect on the continent, it was time to forge forward, to open a new chapter...
Ten years ago, a new era started in the struggle against the Lord’s Resistance Army (LRA) conflict with the incorporation in the USA on September 8th 2004 of Invisible Children Inc. as a non-profit organization....
NUSAF2 in Acholi and Bunyoro Kitgum gets 74 teachers’ units Teachers in Kitgum Demonstration Primary School will for the first time reside in permanent staff quarters. They are full of praises for the Second Northern Uganda Social Action Fund (NUSAF2) Project which made this possible....
Today, the world celebrates Human Rights Day, with the theme; Human Rights 365. The figure 365 encompasses the idea that every day is Human Rights Day....
Justice Law and Order Sector (JLOS) Institutions at district and regional levels that constitute the chain-linked committees are to form case management committees (CMCs) in a move expected to immensely improve and transform the dispensation of justice in the country....
If you traverse this country frequently, chances are high that you have had a torrid drive on a horrible road due to shoddy works. The discomfort you feel while on such roads is the common feeling you share with hundreds of school going children, who are studying in incomplete classroom blocks and...
Related Stories
Do you agree with the ban on the export of maids?
Yes
No
Can't Say
follow us
subscribe to our news letter